Rapid Therapeutic Current Ratio vs. Shares Outstanding
| RTSL Stock | USD 0 0.00 0.00% |
For Rapid Therapeutic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Rapid Therapeutic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Rapid Therapeutic Science utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Rapid Therapeutic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Rapid Therapeutic Science over time as well as its relative position and ranking within its peers.
Rapid |
Rapid Therapeutic Science Shares Outstanding vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Rapid Therapeutic's current stock value. Our valuation model uses many indicators to compare Rapid Therapeutic value to that of its competitors to determine the firm's financial worth. Rapid Therapeutic Science is currently regarded as top stock in current ratio category among its peers. It also is currently regarded as top stock in shares outstanding category among its peers creating about 110,667,000 of Shares Outstanding per Current Ratio. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rapid Therapeutic's earnings, one of the primary drivers of an investment's value.Rapid Shares Outstanding vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Rapid Therapeutic |
| = | 0.07 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Rapid Therapeutic |
| = | 7.75 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Rapid Shares Outstanding Comparison
Rapid Therapeutic is currently under evaluation in shares outstanding category among its peers.
Rapid Therapeutic Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Rapid Therapeutic, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Rapid Therapeutic will eventually generate negative long term returns. The profitability progress is the general direction of Rapid Therapeutic's change in net profit over the period of time. It can combine multiple indicators of Rapid Therapeutic, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc. Rapid Therapeutic operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 8 people.
Rapid Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Rapid Therapeutic. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Rapid Therapeutic position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Rapid Therapeutic's important profitability drivers and their relationship over time.
Use Rapid Therapeutic in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rapid Therapeutic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapid Therapeutic will appreciate offsetting losses from the drop in the long position's value.Rapid Therapeutic Pair Trading
Rapid Therapeutic Science Pair Trading Analysis
The ability to find closely correlated positions to Rapid Therapeutic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rapid Therapeutic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rapid Therapeutic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rapid Therapeutic Science to buy it.
The correlation of Rapid Therapeutic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rapid Therapeutic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rapid Therapeutic Science moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rapid Therapeutic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Rapid Therapeutic position
In addition to having Rapid Therapeutic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sport Products Thematic Idea Now
Sport Products
Companies manufacturing sporting goods and accessories. The Sport Products theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Rapid Pink Sheet
To fully project Rapid Therapeutic's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Rapid Therapeutic Science at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Rapid Therapeutic's income statement, its balance sheet, and the statement of cash flows.